DNA Methylation Markers for Oral Cancer Detection in Non- and Minimally Invasive Samples: a Systematic Review

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2024 Aug 13

PMID 39138540

Authors

Oscar Rapado-Gonzalez

Sofia Salta

Rafael Lopez-Lopez

Rui Henrique

Maria Mercedes Suarez-Cunqueiro

Carmen Jeronimo

Affiliations

Soon will be listed here.

Abstract

More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection. The identification of effective molecular markers by minimally invasive approaches has emerged as a promising strategy for OC screening. This systematic review summarizes and evaluates the performance of the DNA methylation markers identified in non- or minimally invasive samples for OC detection. PubMed's MEDLINE, Scopus, Embase, and Cochrane Library databases were systematically searched for studies that evaluated DNA methylation markers in non-invasive and/or minimally invasive samples (oral rinse/saliva, oral brush, and blood) from OC patients. Two investigators independently extracted data on study population characteristics, candidate methylation markers, testing samples, DNA methylation assay, and performance diagnostic outcomes. Methodological study quality was assessed with the Quality Assessment for Studies of Diagnostic Accuracy-2 tool. Thirty-one studies met the inclusion criteria for this systematic review. DNA methylation markers were evaluated in oral rinse/saliva (n = 17), oral brush (n = 9), and blood (n = 7) samples. Methylation-specific PCR (MSP) and quantitative-MSP were the most common DNA methylation assays. Regarding diagnostic performance values for salivary, oral brush, and blood DNA methylation markers, sensitivity and specificity ranged between 3.4-100% and 21-100%, 9-100% and 26.8-100%, 22-70% and 45.45-100%, respectively. Different gene methylation panels showed good diagnostic performance for OC detection. This systematic review discloses the promising value of testing DNA methylation markers in non-invasive (saliva or oral rinse) or minimally invasive (oral brush or blood) samples as a novel strategy for OC detection. However, further validation in large, multicenter, and prospective study cohorts must be carried out to confirm the clinical value of specific DNA methylation markers in this setting.

Citing Articles

Circulating tumor DNA in head and neck squamous cell carcinoma-current status and future prospects.

Auger S, Mishra V, Singh A, Miao Y, Agrawal N, Izumchenko E Acad Oncol. 2025; 1(2).

PMID: 39867572 PMC: 11760339. DOI: 10.20935/acadonco7456.

References

Rapado-Gonzalez O, Martinez-Reglero C, Salgado-Barreira A, Lopez-Lopez R, Suarez-Cunqueiro M, Muinelo-Romay L . miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis. Oral Oncol. 2019; 99:104465. DOI: 10.1016/j.oraloncology.2019.104465. View

Cohen J, Li L, Wang Y, Thoburn C, Afsari B, Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018; 359(6378):926-930. PMC: 6080308. DOI: 10.1126/science.aar3247. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Cheng S, Chang C, Ko H, Lee J, Chen H, Wang H . Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection. Head Neck. 2017; 40(2):355-368. DOI: 10.1002/hed.24958. View

Adeoye J, Wan C, Zheng L, Thomson P, Choi S, Su Y . Machine Learning-Based Genome-Wide Salivary DNA Methylation Analysis for Identification of Noninvasive Biomarkers in Oral Cancer Diagnosis. Cancers (Basel). 2022; 14(19). PMC: 9563273. DOI: 10.3390/cancers14194935. View

Viet C, Schmidt B . Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev. 2008; 17(12):3603-11. DOI: 10.1158/1055-9965.EPI-08-0507. View

Li Y, St John M, Zhou X, Kim Y, Sinha U, Jordan R . Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004; 10(24):8442-50. DOI: 10.1158/1078-0432.CCR-04-1167. View

Wang Q, Chen Y, Chen Y, Jiang J, Song X, Zhang L . Aberrant promoter methylation of T-cadherin in sera is associated with a poor prognosis in oral squamous cell carcinoma. Neoplasma. 2021; 68(3):528-534. DOI: 10.4149/neo_2021_201110N1203. View

Xu C, Zhao J, Loo W, Hao L, Wang M, Cheung M . Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. Int J Biol Markers. 2012; 27(4):e314-21. DOI: 10.5301/JBM.2012.9937. View

10.

Cordeiro-Silva M, Oliveira Z, Vasconcelos de Podesta J, Gouvea S, von Zeidler S, Louro I . Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep. 2011; 38(8):5435-41. DOI: 10.1007/s11033-011-0698-1. View

11.

Cheng S, Chang C, Lee J, Chen H, Wang H, Liou Y . Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer. Oral Oncol. 2016; 62:34-43. DOI: 10.1016/j.oraloncology.2016.09.007. View

12.

Rosas S, Koch W, da Costa Carvalho M, Wu L, Califano J, Westra W . Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001; 61(3):939-42. View

13.

Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y . Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer. 2012; 118(17):4298-308. DOI: 10.1002/cncr.27417. View

14.

Patel K, Padhya T, Huang J, Hernandez-Prera J, Li T, Chung C . Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma. Mol Carcinog. 2023; 62(4):493-502. PMC: 10023468. DOI: 10.1002/mc.23501. View

15.

Franzmann E, Reategui E, Pedroso F, Pernas F, Karakullukcu B, Carraway K . Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(7):1348-55. DOI: 10.1158/1055-9965.EPI-06-0011. View

16.

Liu Y, Zhou Z, He Q, Jiang W . DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients. Med Oncol. 2011; 29(2):729-33. DOI: 10.1007/s12032-011-9953-5. View

17.

Goel H, Mathur R, Syeda S, Shrivastava A, Jha A . Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population. Asian Pac J Cancer Prev. 2021; 22(3):977-982. PMC: 8286665. DOI: 10.31557/APJCP.2021.22.3.977. View

18.

Zittel S, Moratin J, Horn D, Metzger K, Ristow O, Engel M . Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study. Clin Oral Investig. 2021; 26(2):2055-2064. PMC: 8816316. DOI: 10.1007/s00784-021-04186-y. View

19.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

20.

Liyanage C, Wathupola A, Muraleetharan S, Perera K, Punyadeera C, Udagama P . Promoter Hypermethylation of Tumor-Suppressor Genes , and in Salivary DNA as a Quadruple Biomarker Panel for Early Detection of Oral and Oropharyngeal Cancers. Biomolecules. 2019; 9(4). PMC: 6523930. DOI: 10.3390/biom9040148. View